Tilson Technology Management vs AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos: Revenue, Funding & Team Size Compared
Tilson Technology Management generates $480.4M in revenue; AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos has not disclosed its revenue. The table below compares Tilson Technology Management and AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  Tilson Technology ManagementThis company |  AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos |
|---|---|---|
| Revenue | $480.4M | Not disclosed |
| Team size | 775 | Not disclosed |
| Founded | 1996 | 2024 |
| HQ | Portland, United States | La Roca del Valles, Spain |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Tilson Technology Management at a glance
Tilson Technology Management generates $480.4M in revenue with 775 employees, headquartered in Portland, United States.
- Revenue
- $480.4M
- Team size
- 775
- Founded
- 1996
Provider of network-deployment and information-system professional services to telecom, construction, utility and government clients
AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos at a glance
- Founded
- 2024
Simposios, Cursos y Webinars de AI -Block para Innovar y mejorar Ensayos Clínicos y Fabricación de Medicamentos
Other Tilson Technology Management alternatives
Tilson Technology Management competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Tilson Technology Management vs AIBIEC - Seminarios y Webinars sobre AI-Block para Ensayos Clínicos: frequently asked questions
How much revenue does Tilson Technology Management make?
Tilson Technology Management generates $480.4M in annual revenue with a team of 775.